BBLGW vs. LIDRW

Last updated Aug 1, 2026

BBLGW (Bone Biologics Corp Warrants) and LIDRW (AEye Inc) are both stocks. BBLGW operates in Medical Devices (Healthcare), while LIDRW operates in Software - Infrastructure (Technology). Over the past 3 years, BBLGW returned 69.60%/yr vs -35.37%/yr for LIDRW. Their 0.01 correlation means their historical movements had little consistent relationship.

Performance

BBLGW vs. LIDRW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bone Biologics Corp Warrants (BBLGW) and AEye Inc (LIDRW). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBLGW achieves a -35.48% return, which is significantly higher than LIDRW's -87.24% return.

BBLGW

• 1D: 0.00%
• 1M: -31.03%
• 6M: -36.02%
• YTD: -35.48%
• 1Y: -33.33%
• 3Y*: 69.60%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -17.77%

LIDRW

• 1D: -23.33%
• 1M: -50.00%
• 6M: -84.50%
• YTD: -87.24%
• 1Y: -94.15%
• 3Y*: -35.37%
• 5Y*: -62.20%
• 10Y*: —
• ALL TIME*: -66.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
BBLGW Bone Biologics Corp Warrants	$10.53K	$5.02K	$5.01K
LIDRW AEye Inc	$1.29K	$962.11	$750.45

BBLGW vs. LIDRW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
BBLGW Bone Biologics Corp Warrants	-35.48%	-61.25%	920.41%	638.23%	-97.47%	-17.84%
LIDRW AEye Inc	-87.24%	12.62%	1,233.33%	-85.00%	-95.70%	6.91%

Correlation

The correlation between BBLGW and LIDRW is -0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	-0.01
Correlation (3Y) Balances recent behavior with more history.	-0.01
Correlation (All Time) Calculated using the full available price history since Oct 13, 2021	0.01

Fundamentals

Market Cap BBLGW : $1.79M LIDRW : $36.82M
EPS BBLGW : -$1.80 LIDRW : -$0.85
PB Ratio BBLGW : 3.84 LIDRW : 0.01
Total Revenue (TTM) BBLGW : $0.00 LIDRW : $270.00K
Gross Profit (TTM) BBLGW : $0.00 LIDRW : -$389.00K
EBITDA (TTM) BBLGW : -$2.90M LIDRW : -$35.49M

Return for Risk

BBLGW vs. LIDRW — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BBLGW

BBLGW Risk / Return Rank: 41
BBLGW Sharpe Ratio Rank: 33
BBLGW Sortino Ratio Rank: 49
BBLGW Omega Ratio Rank: 65
BBLGW Calmar Ratio Rank: 29
BBLGW Martin Ratio Rank: 26

LIDRW

LIDRW Risk / Return Rank: 20
LIDRW Sharpe Ratio Rank: 27
LIDRW Sortino Ratio Rank: 32
LIDRW Omega Ratio Rank: 32
LIDRW Calmar Ratio Rank: 1
LIDRW Martin Ratio Rank: 7

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BBLGW vs. LIDRW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bone Biologics Corp Warrants (BBLGW) and AEye Inc (LIDRW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BBLGW	LIDRW	Difference
Sharpe ratio: Return per unit of total volatility	-0.24	-0.38	+0.14
Sortino ratio: Return per unit of downside risk	0.62	-0.03	+0.65
Omega ratio: Gain probability vs. loss probability	1.16	1.00	+0.17
Calmar ratio: Return relative to maximum drawdown	-0.43	-1.00	+0.57
Martin ratio: Return relative to average drawdown	-0.87	-1.45	+0.58

BBLGW vs. LIDRW - Sharpe Ratio Comparison

The current BBLGW Sharpe Ratio is -0.24, which is higher than the LIDRW Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of BBLGW and LIDRW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BBLGW vs. LIDRW - Drawdown Comparison

The maximum BBLGW drawdown since its inception was -98.80%, roughly equal to the maximum LIDRW drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for BBLGW and LIDRW.

Drawdown Indicators

	BBLGW	LIDRW	Difference
Max Drawdown Largest peak-to-trough decline	-98.80%	-99.93%	+1.13%
Max Drawdown (1Y) Largest decline over 1 year	-77.75%	-95.31%	+17.56%
Max Drawdown (3Y) Largest decline over 3 years	-96.92%	-97.19%	+0.27%
Max Drawdown (5Y) Largest decline over 5 years	—	-99.80%	—
Current Drawdown Current decline from peak	-89.47%	-99.77%	+10.30%
Average Drawdown Average peak-to-trough decline	-71.30%	-92.20%	+20.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	38.28%	67.47%	-29.19%

Volatility

BBLGW vs. LIDRW - Volatility Comparison

The current volatility for Bone Biologics Corp Warrants (BBLGW) is 64.51%, while AEye Inc (LIDRW) has a volatility of 103.50%. This indicates that BBLGW experiences smaller price fluctuations and is considered to be less risky than LIDRW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBLGW	LIDRW	Difference
Volatility (1M) Calculated over the trailing 1-month period	64.51%	103.50%	-38.99%
Volatility (6M) Calculated over the trailing 6-month period	129.60%	213.38%	-83.78%
Volatility (1Y) Calculated over the trailing 1-year period	139.64%	252.02%	-112.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	249.50%	363.35%	-113.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	249.50%	347.93%	-98.43%

Dividends

BBLGW vs. LIDRW - Dividend Comparison

Neither BBLGW nor LIDRW has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both BBLGW and LIDRW in my portfolio?

BBLGW and LIDRW have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBLGW or LIDRW?

LIDRW has higher volatility (103.50%) compared to BBLGW (64.51%). In terms of maximum drawdown, BBLGW dropped -98.80% vs LIDRW's -99.93%.

Which has better risk-adjusted returns?

BBLGW currently has the higher Sharpe Ratio (-0.24 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.